FDA Inspection 1125211 — George A. Diaz, M.D.

George A. Diaz, M.D. — FEI 3016998503

The FDA completed an inspection of George A. Diaz, M.D. on July 17, 2020 in Everett, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 17, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Everett, WA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance